IFNG and melanoma: Moreover, ongoing phase III clinical trials (NCT00001296) investigating the combination of TNF‐α and IFN‐γ with hyperthermia isolated limb perfusion (HILP) in patients with locally advanced melanoma hold promise for achieving positive outcomes.